Photo of Hope Rugo from ucsfhealth.org
May 18, 2024, 08:47
Elisa Agostinetto: At ESMO Breast24, Hope Rugo presents results of CAPItello-291
Elisa Agostinetto, Clinical Research Fellow at Institute Jules Bordet, shared a post on X/Twitter:
”At ESMO Breast24, Hope Rugo presents results of CAPItello-291: Capivasertib + fulvestrant in aromatase inhibitor-resistant HR+/HER2 – ABC showed significant increase in:
- PFS2.
- Time to subsequent CT.
Improvements both in the overall and PIK3CA/AKT1/PTEN altered populations.”
Source: Elisa Agostinetto/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 12:32
Mar 29, 2025, 12:06
Mar 29, 2025, 12:00
Mar 29, 2025, 11:58
Mar 29, 2025, 11:36
Mar 29, 2025, 11:26
Mar 29, 2025, 11:03
Mar 29, 2025, 10:55